Agilent Technologies A

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.15 (+0.12%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Agilent Technologies (A)
    Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $126.7

    • Market Cap

      $36.14 Billion

    • Price-Earnings Ratio

      29.81

    • Total Outstanding Shares

      285.29 Million Shares

    • Total Employees

      17,900

    • Dividend

      $0.25 Per Share Quarterly

    • IPO Date

      November 18, 1999

    • SIC Description

      Laboratory Analytical Instruments

    • Primary Exchange

      New York Stock Exchange

    • Type

      Common Stock

    • Headquarters

      5301 stevens creek blvd, Santa clara, CA, 95051

    • Homepage

      https://www.agilent.com

    Historical Stock Splits

    If you bought 1 share of A before November 3, 2014, you'd have 1.40 shares today.
    Execution DateSplit Amount
    November 3, 20141398-for-1000

    Cash Flow Statement

    May 1, 2023 to April 30, 2024
    MetricValue
    Net Cash Flow From Investing Activities, Continuing$-333 Million
    Exchange Gains/Losses$-13 Million
    Net Cash Flow From Financing Activities$-1.05 Billion
    Net Cash Flow From Investing Activities$-333 Million
    Net Cash Flow From Operating Activities, Continuing$1.90 Billion
    Net Cash Flow$496 Million

    Income Statement

    May 1, 2023 to April 30, 2024
    MetricValue
    Income Tax Expense/Benefit$87 Million
    Costs And Expenses$5.30 Billion
    Benefits Costs and Expenses$5.26 Billion
    Gross Profit$3.34 Billion
    Net Income/Loss Attributable To Noncontrolling Interest$0
    Revenues$6.59 Billion

    Comprehensive Income

    May 1, 2023 to April 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss Attributable To Parent$1.19 Billion
    Other Comprehensive Income/Loss$-55 Million
    Comprehensive Income/Loss$1.19 Billion

    Balance Sheet

    May 1, 2023 to April 30, 2024
    MetricValue
    Liabilities$4.64 Billion
    Noncurrent Assets$6.65 Billion
    Other Current Liabilities$1.17 Billion
    Accounts Payable$461 Million
    Equity$6.21 Billion
    Inventory$1 Billion

    Historical Dividends

    Current dividend: $0.25 Per Share Quarterly
    Announcement DatePayment DateRecord DateAmountFrequency
    Feb 19, 2025Apr 23, 2025Apr 1, 2025$0.248Quarterly
    Nov 20, 2024Jan 22, 2025Dec 31, 2024$0.248Quarterly
    Sep 18, 2024Oct 23, 2024Oct 1, 2024$0.236Quarterly
    May 22, 2024Jul 24, 2024Jul 2, 2024$0.236Quarterly
    Feb 21, 2024Apr 24, 2024Apr 2, 2024$0.236Quarterly
    Nov 15, 2023Jan 24, 2024Jan 2, 2024$0.236Quarterly

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about A from trusted financial sources

      Related Companies

      Additional publicly traded companies similar to Agilent Technologies (A)
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.